Literature DB >> 28275136

Distinct and Overlapping Functions of TEC Kinase and BTK in B Cell Receptor Signaling.

Marjolein J W de Bruijn1, Jasper Rip1, Esmee K van der Ploeg1, Lars W van Greuningen1, Van T B Ta1, Laurens P Kil1, Anton W Langerak2, Guus F Rimmelzwaan3, Wilfried Ellmeier4, Rudi W Hendriks5, Odilia B J Corneth1.   

Abstract

The Tec tyrosine kinase is expressed in many cell types, including hematopoietic cells, and is a member of the Tec kinase family that also includes Btk. Although the role of Btk in B cells has been extensively studied, the role of Tec kinase in B cells remains largely unclear. It was previously shown that Tec kinase has the ability to partly compensate for loss of Btk activity in B cell differentiation, although the underlying mechanism is unknown. In this study, we confirm that Tec kinase is not essential for normal B cell development when Btk is present, but we also found that Tec-deficient mature B cells showed increased activation, proliferation, and survival upon BCR stimulation, even in the presence of Btk. Whereas Tec deficiency did not affect phosphorylation of phospholipase Cγ or Ca2+ influx, it was associated with significantly increased activation of the intracellular Akt/S6 kinase signaling pathway upon BCR and CD40 stimulation. The increased S6 kinase phosphorylation in Tec-deficient B cells was dependent on Btk kinase activity, as ibrutinib treatment restored pS6 to wild-type levels, although Btk protein and phosphorylation levels were comparable to controls. In Tec-deficient mice in vivo, B cell responses to model Ags and humoral immunity upon influenza infection were enhanced. Moreover, aged mice lacking Tec kinase developed a mild autoimmune phenotype. Taken together, these data indicate that in mature B cells, Tec and Btk may compete for activation of the Akt signaling pathway, whereby the activating capacity of Btk is limited by the presence of Tec kinase.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28275136     DOI: 10.4049/jimmunol.1601285

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Unique Transcriptome Changes in Peripheral B Cells Revealed by Comparing Age Groups From Naive or Vaccinated Mice, Including snoRNA and Cdkn2a.

Authors:  Robin L Baudier; Kevin J Zwezdaryk; Malwina Czarny-Ratajczak; Lauren H Kodroff; Deborah E Sullivan; Elizabeth B Norton
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-11-13       Impact factor: 6.053

2.  Novel mouse model resistant to irreversible BTK inhibitors: a tool identifying new therapeutic targets and side effects.

Authors:  H Yesid Estupiñán; Thibault Bouderlique; Chenfei He; Anna Berglöf; Dhanu Gupta; Osama Saher; Miguel Ángel Daza Cruz; Lucia Peña-Perez; Liang Yu; Rula Zain; Mikael C I Karlsson; Robert Månsson; C I Edvard Smith
Journal:  Blood Adv       Date:  2020-06-09

Review 3.  Targeting B cell receptor signalling in cancer: preclinical and clinical advances.

Authors:  Jan A Burger; Adrian Wiestner
Journal:  Nat Rev Cancer       Date:  2018-01-19       Impact factor: 60.716

Review 4.  Role of Bruton's tyrosine kinase in B cells and malignancies.

Authors:  Simar Pal Singh; Floris Dammeijer; Rudi W Hendriks
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.